VIE/EVT (VIE/EVT)

Vienna Stock Exchange: VIE/EVT · EUR

€2.94

+0.01 (+0.3%)· Recorded snapshot

Market cap	520.8M
Revenue (ttm)	717.3M
Net income (ttm)	-197M
EPS (ttm)	-€1.11
Volume	1,687

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 717.3M
Net income (ttm): -197M
EPS (ttm): -€1.11
Market cap: 520.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-26.1

P25 4.8P50 10.6P75 20.1

ROIC-22.1

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/EVT indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

EUR

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-05
Employees	4,461
Employees change	-219
Employees growth	-4.37%
Enterprise value	EUR 531.1M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1993
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	DE0005664809
Last earnings date	2026-08-13
Last refreshed	2026-10-30
Market cap	EUR 520.8M
Next earnings date	2026-11-05
Price	EUR 2.94
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/EVT
Website	https://www.evotec.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-37.73%
EV/Sales	0.74x
FCF / EV yield	-30.73%
FCF yield	-31.34%
P/B ratio	0.78x
P/S ratio	0.73x
Price / tangible book value	1.45x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-20.33%
EBITDA margin	-10.2%
Gross margin	8.46%
Operating margin	-20.33%
Pretax margin	-25.62%
Profit margin	-27.47%
Profit per employee	EUR -44,171
Revenue per employee	EUR 160,790
ROA	-5.39%
ROA (5Y)	-0.74%
ROCE	-11.56%
ROE	-26.08%
ROE (5Y)	-6.22%
ROIC	-22.13%
ROIC (5Y)	-2.38%
SBC / revenue	0.53%
Tax / revenue	1.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	-47.09%
Gross profit growth 3Y	-33.92%
Gross profit growth 5Y	-13.99%
Net income growth years	1
Revenue growth	-7.73%
Revenue growth (Q)	-16.21%
Revenue growth (QoQ)	-8.4%
Revenue growth 10Y	17.08%
Revenue growth 3Y	-3.51%
Revenue growth 5Y	5.79%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -48.2M
Depreciation and amortization	EUR 72.7M
EBIT	EUR -145.9M
EBITDA	EUR -73.2M
EPS	EUR -1.11
Financing cash flow	EUR -24.6M
Free cash flow	EUR -163.2M
Free cash flow minus SBC	EUR -167M
Gross profit	EUR 60.7M
Income taxes	EUR 13.3M
Investing cash flow	EUR 222.2M
Net borrowing	EUR -17M
Net cash flow	EUR 80.5M
Net income	EUR -197M
Operating cash flow minus SBC	EUR -118.8M
Operating income	EUR -145.9M
Revenue	EUR 717.3M
Stock-based compensation	EUR 3.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.3
Book value per share	EUR 3.75
Debt / equity	0.71
Goodwill	EUR 274.7M
Long-term assets	EUR 845.1M
Long-term liabilities	EUR 595.9M
Net cash (debt)	EUR -10.3M
Net cash / market cap	-1.97%
Net debt / equity	0.02
Piotroski F-Score	4
Property, plant and equipment	EUR 449.8M
Shareholders' equity	EUR 665.6M
Tangible book value	EUR 359.1M
Tangible book value per share	EUR 2.02
Total assets	EUR 1.6B
Total cash	EUR 465.6M
Total debt	EUR 475.9M
Total liabilities	EUR 908.4M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.42
Current assets	EUR 728.9M
Current liabilities	EUR 312.5M
Current ratio	2.33
Inventory turnover	17.96
Net working capital	EUR 12.4M
Quick ratio	2.02
Working capital	EUR 416.4M
Working capital turnover	2.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.09%
Shareholder yield	-0.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 4.05
1D price change	0.27%
1M price change	2.51%
1M total return	2.51%
1W price change	0.55%
1W total return	0.55%
1Y price change	-58.34%
1Y return CAGR	-58.37%
1Y total return	-58.34%
20-day SMA	EUR 2.80
200-day SMA	EUR 4.42
3M price change	-15.75%
3M total return	-15.75%
3Y price change	-81.68%
3Y return CAGR	-43.2%
3Y total return	-81.68%
50-day SMA	EUR 2.97
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 7.16
52-week high date	2025-11-03
52-week low	EUR 2.42
52-week low date	2026-10-13
5Y price change	-92.99%
5Y return CAGR	-41.23%
5Y total return	-92.99%
6M price change	-43.26%
6M total return	-43.26%
All-time high	EUR 45.74
All-time high date	2021-09-16
All-time low	EUR 2.42
All-time low date	2026-10-13
Average true range (ATR)	EUR 0.11
Average volume	320.4
Change from 52-week high	-58.91%
Change from 52-week low	21.57%
Change from all-time high	-93.57%
Change from all-time low	21.57%
Change from open	-1.34%
Day's gap	1.64%
Dollar volume	EUR 4,963
High price	EUR 2.98
Low price	EUR 2.92
Monthly RSI	32.33
Open price	EUR 2.98
Position in 52-week range	31.03%
Previous close	EUR 2.93
Price vs 150-day SMA	-27.36%
Price vs 20-day SMA	5.11%
Price vs 200-day SMA	-33.38%
Price vs 50-day SMA	-1.01%
Relative volume	5.27
RSI	54.09
Sharpe ratio	-1.3
Sharpe ratio (3Y)	-0.57
Sharpe ratio (5Y)	-0.66
Sortino ratio	-1.51
Sortino ratio (3Y)	-0.65
Sortino ratio (5Y)	-0.78
Volume	1.7K
Weekly RSI	36.44
YTD price change	-45.7%
YTD total return	-45.7%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	147M
Shares change (QoQ)	0.06%
Shares change (YoY)	0.09%
Shares held by insiders	0.17%
Shares held by institutions	30.34%

Deeper analysis on VIE/EVT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/EVT report

Is a complete VIE/EVT research report available?

No complete published report is available for vie/EVT (VIE/EVT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/EVT (VIE/EVT)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/EVT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/EVT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/EVT

Frequently asked questions